Table 7.
Individual constant elimination rate (yearly) and half-life (year) in the 17 airport employees for long-chain PFAS.
Subject | Sample counts | PFOA | PFHxS | PFHpS | L-PFOS | 1m-PFOS | 3/4/5m-PFOS | 2/6m-PFOS | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Elimination ratea | HLa | -Valuea | Elimination rate | HL | -Value | Elimination rate | HL | -Value | Elimination rate | HL | -Value | Elimination rate | HL | -Value | Elimination rate | HL | -Value | Elimination rate | HL | -Value | ||
1 | 5 | 0.3 | 2.4 | 0.17 | 0.2 | 3.5 | 0.19 | 0.5 | 1.3 | 0.31 | NA | 0.30 | 0.3 | 2.0 | 0.10 | 0.4 | 1.9 | 0.13 | NA | 0.76 | ||
2 | 5 | 0.2 | 2.9 | 0.27 | 0.3 | 2.0 | 0.09 | 0.2 | 3.4 | 0.64 | 0.4 | 1.7 | 0.07 | 0.1 | 5.4 | 0.83 | 0.3 | 2.1 | 0.11 | 0.5 | 1.3 | 0.20 |
3 | 5 | 0.6 | 1.2 | 0.04 | 0.5 | 1.5 | 0.09 | 0.2 | 3.0 | 0.34 | 0.5 | 1.3 | 0.21 | 0.8 | 0.9 | 0.09 | 0.4 | 1.7 | 0.15 | 0.7 | 1.0 | 0.12 |
4 | 5 | 0.3 | 2.3 | 0.15 | 0.1 | 9.6 | 0.75 | 0.001 | 526 | 1.00 | NA | 0.24 | NA | 0.78 | 0.1 | 11 | 0.87 | 0.0 | 51 | 0.97 | ||
5 | 5 | 0.3 | 2.2 | 0.15 | 0.1 | 4.7 | 0.20 | NA | 0.19 | 0.6 | 1.2 | 0.13 | 0.1 | 5.9 | 0.75 | 0.2 | 3.1 | 0.16 | 0.4 | 1.6 | 0.56 | |
6 | 4 | 0.2 | 2.9 | 0.39 | NAb | 0.42 | 0.1 | 6.1 | 0.43 | 0.04 | 17 | 0.87 | NA | 0.51 | 0.04 | 19 | 0.49 | 0.4 | 1.7 | 0.04 | ||
7 | 5 | 0.4 | 1.6 | 0.03 | 0.3 | 2.3 | 0.02 | NA | 0.88 | 0.006 | 108 | 0.92 | NA | 0.03 | 0.1 | 4.8 | 0.02 | 1.1 | 0.6 | 0.29 | ||
8 | 5 | 0.007 | 100 | 0.98 | NA | 0.94 | NA | 0.42 | 0.23 | NA | 0.13 | NA | 0.24 | NA | 0.44 | |||||||
9 | 5 | 0.4 | 1.9 | 0.05 | NA | 0.81 | 0.05 | 15 | 0.69 | 0.4 | 1.8 | 0.21 | NA | 0.10 | 0.1 | 10 | 0.70 | 0.2 | 4.2 | 0.50 | ||
10 | 5 | 0.3 | 2.1 | 0.25 | 0.4 | 1.9 | 0.11 | 0.4 | 1.8 | 0.46 | NA | 0.32 | 0.6 | 1.2 | 0.10 | 0.2 | 4.0 | 0.52 | NA | 0.97 | ||
11 | 5 | 0.5 | 1.5 | 0.12 | 0.2 | 3.0 | 0.39 | 1.7 | 0.4 | 0.20 | 0.1 | 4.7 | 0.56 | 1.9 | 0.4 | 0.15 | 2.0 | 0.4 | 0.15 | 1.7 | 0.4 | 0.10 |
12 | 5 | 0.7 | 1.0 | 0.00 | 0.4 | 1.6 | 0.04 | 0.6 | 1.1 | 0.08 | 0.8 | 0.9 | 0.01 | 0.03 | 26 | 0.95 | 0.5 | 1.3 | 0.09 | 1.7 | 0.4 | 0.03 |
13 | 5 | 0.4 | 1.6 | 0.02 | 0.5 | 1.4 | 0.01 | NA | 0.70 | 0.2 | 3.7 | 0.34 | 1.1 | 0.6 | 0.08 | 0.5 | 1.5 | 0.04 | 1.0 | 0.7 | 0.20 | |
14 | 4 | 0.4 | 1.6 | 0.40 | 0.6 | 1.2 | 0.31 | 1.0 | 0.7 | 0.21 | 0.3 | 2.0 | 0.67 | 1.7 | 0.4 | 0.08 | 0.3 | 2.0 | 0.55 | 1.5 | 0.5 | 0.44 |
15 | 5 | 0.6 | 1.1 | 0.04 | 0.3 | 2.2 | 0.06 | 1.6 | 0.4 | 0.09 | 0.5 | 1.3 | 0.01 | 1.3 | 0.6 | 0.18 | 2.2 | 0.3 | 0.08 | 1.2 | 0.6 | 0.18 |
16 | 5 | 0.3 | 2.7 | 0.19 | 0.04 | 19 | 0.89 | 0.1 | 12 | 0.61 | 0.6 | 1.2 | 0.05 | NA | 0.02 | 0.3 | 2.0 | 0.12 | NA | 0.81 | ||
17 | 5 | 0.6 | 1.2 | 0.09 | 0.4 | 1.6 | 0.07 | 1.7 | 0.4 | 0.13 | 0.3 | 2.1 | 0.19 | 2.2 | 0.3 | 0.12 | 1.9 | 0.4 | 0.13 | 1.9 | 0.4 | 0.10 |
Note: HL, half-life; L-PFOS, linear perfluorooctane sulfonic acid; PFAS, perfluoroalkyl substances; PFHpS, perfluoroheptane sulfonic acid; PFHxS, perfluorohexane sulfonic acid; PFOA, perfluorooctanoic acid; 1m-PFOS, branched, perfluoro-1-methylheptanesulfonate; 2/6m-PFOS, branched, sum of perfluoro-2/6-methylheptanesulfonate; 3/4/5m-PFOS, branched, sum of perfluoro-3/4/5-methylheptanesulfonate.
The elimination rate and -value were obtained from linear regression. Serum PFAS levels were log-transformed. The elimination rate denotes the negative value of the slope () from the model, and half-life is calculated as .
Not applicable because the elimination rate was negative, indicating PFAS levels did not decrease during the 5-month follow-up.